TrialDiabetes, obesity & metabolism2018

Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study.

Ronnie Aronson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.